Holen Sie sich die Stockscreener-App
5.09
9.23%
0.43
Schlusskurs vom Vortag:
$4.66
Offen:
$4.68
24-Stunden-Volumen:
6.50M
Relative Volume:
3.59
Marktkapitalisierung:
$490.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.49M
KGV:
-6.2917
EPS:
-0.809
Netto-Cashflow:
$-73.48M
1W Leistung:
+10.65%
1M Leistung:
+0.00%
6M Leistung:
+54.71%
1J Leistung:
-26.87%
1-Tages-Spanne:
$4.646
$5.635
1-Wochen-Bereich:
$4.56
$5.635
52-Wochen-Spanne:
$1.07
$11.46
Rezolute Inc Stock (RZLT) Company Profile
Firmenname
Rezolute Inc
Sektor
Branche
Telefon
650-206-4507
Adresse
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
5.09 | 448.72M | 0 | -81.49M | -73.48M | -0.809 |
VRTX
Vertex Pharmaceuticals Inc
|
548.05 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
834.04 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,039.78 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.13 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.46 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-25 | Hochstufung | Wedbush | Neutral → Outperform |
| 2025-12-11 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-12-11 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-12-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-11-05 | Eingeleitet | Wedbush | Outperform |
| 2024-08-27 | Eingeleitet | Guggenheim | Buy |
| 2024-07-17 | Eingeleitet | BTIG Research | Buy |
| 2024-06-04 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-09 | Eingeleitet | Maxim Group | Buy |
| 2022-08-02 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-27 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Rezolute Inc Aktie (RZLT) Neueste Nachrichten
Balyasny Asset Management L.P. Reduces Stake in Rezolute Inc (RZ - GuruFocus
Rezolute, Inc. (NASDAQ:RZLT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Bank of New York Mellon Corp Sells 481,913 Shares of Rezolute, Inc. $RZLT - MarketBeat
Rezolute Stock Price Forecast. Should You Buy RZLT? - StockInvest.us
Balyasny reports 4.84% Rezolute (RZLT) stake in Schedule 13G/A - Stock Titan
Rezolute, Inc. $RZLT Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
Bank of America Corp (RZLT) discloses 1.2% Rezolute ownership in 13G/A - Stock Titan
Rezolute, Inc. (RZLT) gains 5.9% reported stake from Dellora Investments - Stock Titan
Rezolute Inc (RZLT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rezolute Inc (RZLT) Stock News Today - TradingKey
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - The National Law Review
RZLT Q2 2026 Earnings: Loss Narrows 12.33% vs. Estimates; Shares Slip 3.28%Estimate Dispersion - vinanet.vn
Rezolute (RZLT) Pulls Back 5.4% as Biotech Volatility ResurfacesWide Range Bar - dars.gov.et
H.C. Wainwright reiterates Rezolute stock rating at buy, $5 target By Investing.com - Investing.com Canada
H.C. Wainwright Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $5 - moomoo.com
RZLT|Rezolute Inc|Price:4.930|Chg%:-0.060 - TradingKey
RZLT|Rezolute Inc|Price:4.990| - TradingKey
Rezolute Inc (RZLT) Balance Sheet - TradingKey
Rezolute Inc (RZLT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rezolute Inc (RZLT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rezolute Inc (RZLT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rezolute Inc (RZLT) Institutional Confidence - TradingKey
Rezolute Inc (RZLT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rezolute Inc (RZLT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rezolute Inc (RZLT) Income Statement - tradingkey.com
Rezolute Inc (RZLT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Rezolute to Participate in the BTIG Virtual Biotechnology Conference - The Manila Times
Rezolute Management to Meet Investors Online July 28-29 - Stock Titan
Rezolute to join BTIG Virtual Biotechnology Con... - Pluang
Rezolute (RZLT) Q2 2026 Earnings: EPS Beat with 12.33% Surprise Amid No RevenuePeak Earnings Alert - dars.gov.et
Is Rezolute (NASDAQ:RZLT) In A Good Position To Deliver On Growth Plans? - Moomoo
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Rezolute Inc. (RZLT) Edges Higher Amid Positive Momentum, Testing Key ResistanceVWAP Breakout - vinanet.vn
Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar - simplywall.st
Rezolute Q2 2026 Earnings: EPS Beat Estimates but Stock Declines Amid No RevenueEarnings Acceleration Picks - dars.gov.et
Rezolute (RZLT) CMO disposes 3,062 shares in mandated RSU tax sale - Stock Titan
Form 4 Rezolute Inc For: 7 July By Investing.com - Investing.com Nigeria
Rezolute (RZLT) CEO logs automatic RSU tax-withholding share sale in Form 4 - Stock Titan
Rezolute (RZLT) CFO logs RSU tax sell-to-cover, retains 411,400 shares - Stock Titan
RZLTRezolute Inc Options - Finviz
RZLT News | REZOLUTE INC (NASDAQ:RZLT) - ChartMill
Price to earnings forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Price to book forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Price to earnings forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Enterprise value to revenue forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Enterprise value to revenue forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Enterprise value to EBITDA forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Enterprise value to EBIT forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Price to sales forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Enterprise value to EBIT forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Price to sales forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Finanzdaten der Rezolute Inc-Aktie (RZLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.21%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):